Evidence-based knowledge for a healthier tomorrow
CannaQ reads the research on medical cannabis and cannabinoids, grades how strong it is, and explains it in plain English.
From the blog
Every article is built from sources we can name and checked by a person before it goes live. The first articles are in preparation.
- In preparation
Pioneers of cannabinoid science: Raphael Mechoulam
A sourced timeline of the discoveries that shaped the field, and what they do and don’t tell us about treatment.
- Planned
How to read a clinical trial
What sample size, control groups and blinding tell you, and what a headline leaves out.
- Planned
THC and CBD are not the same thing
Two cannabinoids with different effects and different risks.
How we grade evidence
Not all research is equal. Select a level to see what it can and can’t show.
What we follow
We track new studies, clinical trials and safety findings in these areas.
- Chronic pain
- Epilepsy
- Multiple sclerosis
- Spinal cord injuries
- Sleep disorders
- Inflammation
- Rheumatoid arthritis
- Anxiety and mental health
- PTSD
- Autism spectrum disorder
- ADHD
- Cancer-related symptoms
- Palliative care
- Drug interactions
- Long-term safety
A topic on this list does not mean a proven cannabis treatment exists.
Independent by design
CannaQ’s content is never shaped by funding. Every article is checked against its sources and approved by a person before it is published, and we correct mistakes openly. We do not promote cannabis products or sales.
If CannaQ ever receives funding or enters a partnership, we will list it on this page and label it clearly. As of today, CannaQ has no sponsors or partners.